“Sensory neuroimmune signaling opens a new precision medicine window for Stevens–Johnson syndrome and toxic epidermal necrolysis” (2026) Novera, 1(1). Available at: https://submit.noverapress.com/index.php/Novera/article/view/10 (Accessed: 22 April 2026).